China Adeno Associated Virus CDMO Market (2025-2031) | Share, Outlook, Competition, Drivers, Demand, Segmentation, Value, Opportunities, Investment Trends, Supply, Analysis, Segments, Challenges, Pricing Analysis, Strategic Insights, Consumer Insights, Competitive, Industry, Growth, Trends, Strategy, Restraints, Companies, Forecast, Size, Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Adeno Associated Virus CDMO Market Revenues & Volume, 2021 & 2031F

3.3 China Adeno Associated Virus CDMO Market - Industry Life Cycle

3.4 China Adeno Associated Virus CDMO Market - Porter's Five Forces

3.5 China Adeno Associated Virus CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F

3.6 China Adeno Associated Virus CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 China Adeno Associated Virus CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for gene therapy solutions in China

4.2.2 Rising prevalence of genetic disorders driving the need for gene therapy

4.2.3 Favorable government initiatives supporting the biopharmaceutical industry in China

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for gene therapy products in China

4.3.2 High initial investment and infrastructure costs for setting up adeno-associated virus (AAV) manufacturing facilities

6.1 China Adeno Associated Virus CDMO Market, By Service Type

6.1.1 Overview and Analysis

6.1.2 China Adeno Associated Virus CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F

6.1.3 China Adeno Associated Virus CDMO Market Revenues & Volume, By Process Development, 2021 - 2031F

6.1.4 China Adeno Associated Virus CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F

6.1.5 China Adeno Associated Virus CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F

6.1.6 China Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F

6.2 China Adeno Associated Virus CDMO Market, By Application

6.2.1 Overview and Analysis

6.2.2 China Adeno Associated Virus CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F

6.2.3 China Adeno Associated Virus CDMO Market Revenues & Volume, By Vaccine Development, 2021 - 2031F

6.2.4 China Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F

6.3 China Adeno Associated Virus CDMO Market, By End User

6.3.1 Overview and Analysis

6.3.2 China Adeno Associated Virus CDMO Market Revenues & Volume, By Biotechnology, 2021 - 2031F

6.3.3 China Adeno Associated Virus CDMO Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F

6.3.4 China Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F

7.1 China Adeno Associated Virus CDMO Market Export to Major Countries

7.2 China Adeno Associated Virus CDMO Market Imports from Major Countries

8.1 Research and development (RD) investment in gene therapy technologies

8.2 Number of partnerships and collaborations in the gene therapy sector

8.3 Capacity utilization rate of AAV manufacturing facilities

9.1 China Adeno Associated Virus CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F

9.2 China Adeno Associated Virus CDMO Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 China Adeno Associated Virus CDMO Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 China Adeno Associated Virus CDMO Market Revenue Share, By Companies, 2024

10.2 China Adeno Associated Virus CDMO Market Competitive Benchmarking, By Operating and Technical Parameters